Nephrotoxicity of chlorofluoroacetic acid in rats

Toxicological Sciences

Volumn 70, Issue 2, 2002, Pages 261-268

  Lantum, Hoffman B M ^a   Baggs, Raymond B ^a   Krenitsky, Daria M ^a   Anders, M W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Chlorofluoroacetic acid; Difluoroacetic acid; Fluoride; Glutathione transferase zeta; Lactic acidosis; Nephrotoxicity

Indexed keywords

ACETIC ACID DERIVATIVE; CHLOROFLUOROACETIC ACID; DICHLOROACETIC ACID; DIFLUOROACETIC ACID; FLUORIDE; GLUTATHIONE TRANSFERASE; INORGANIC COMPOUND; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANURIA; APOPTOSIS; CATALYSIS; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; ENZYME INACTIVATION; ENZYME METABOLISM; EXCRETION; FATALITY; GLUCOSURIA; KIDNEY DISTAL TUBULE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MALE; NEPHROTOXICITY; NONHUMAN; POLYURIA; RAT; REVIEW; TOXICOKINETICS; URINALYSIS; URINE VOLUME;

ACETIC ACIDS; ANIMALS; DICHLOROACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORIDES; FLUOROACETATES; GLUTATHIONE TRANSFERASE; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MALE; MICROSCOPY, ELECTRON; RATS; RATS, INBRED F344; TIME FACTORS; URINALYSIS;

ANIMALIA; CELL FUSING AGENT VIRUS; RODENTIA;

EID: 0036902601     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/70.2.261     Document Type: Review

References (34)

1. Anders, M. W. (1980). Metabolism of drugs by the kidney. Kidney Int. 18, 636-647.
2. Anders, M. W. (1991). Metabolism and toxicity of hydrochlorofluorocarbons: Current knowledge and needs for the future. Environ. Health Perspect. 96, 185-191.
3. Anders, M. W., and Dekant, W. (1998). Glutathione-dependent bioactivation of haloalkenes. Annu. Rev. Pharmacol. Toxicol. 38, 501-537.
4. Anderson, W. B., Board, P. G., Gargano, B., and Anders, M. W. (1999). Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking α-haloalkanoic acids. Chem. Res. Toxicol. 12, 1144-1149.
5. Chen, J., Liu, X., Mandel, L. J., and Schnellmann, R. G. (2001). Progressive disruption of the plasma membrane during renal proximal tubule cellular injury. Toxicol. Appl. Pharmacol. 171, 1-11.
6. Cittanova, M.-L., Lelongt, B., Verpont, M. C., Géniteau-Legendre, M., Wahbé, F., Prié, D., Coriat, P., and Ronco, P. M. (1996). Fluoride ion toxicity in human kidney collecting duct cells. Anesthesiology 84, 428-435.
7. Cornett, R., James, M. O., Henderson, G. N., Cheung, J., Shroads, A. L., and Stacpoole, P. W. (1999). Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: A potential unifying mechanism for its altered biotransformation and toxicity. Biochem. Biophys. Res. Commun. 262, 752-756.
8. Dekant, W., Lash, L. H., and Anders, M. W. (1987). Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoro-ethyl)-L-cysteine. Proc. Natl. Acad. Sci. U.S.A. 84, 7443-7447.
9. Hargus, S. J., Fitzsimmons, M. E., Aniya, Y., and Anders, M. W. (1991). Stereochemistry of the microsomal glutathione S-transferase-catalyzed addition of glutathione to chlorotrifluoroethene. Biochemistry 30, 717-721.
10. Heyman, S. N., Brezis, M., Epstein, F. H., Spokes, K., and Rosen, S. (1992). Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy. Am. J. Kidney Dis. 19, 578-586.
11. 14C]dichloroacetate in male Sprague-Dawley rats. Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate. Drug Metab. Dispos. 26, 1134-1143.
12. Kharasch, E. D., Hankins, D. C., and Thummel, K. E. (1995). Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 82, 689-699.
13. Kharasch, E. D., and Thummel, K. E. (1993). Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79, 795-807.
14. Lantum, H. B., Baggs, R. B., Krenitsky, D. M., Board, P. G., and Anders, M. W. (2002). Immunohistochemical localization and activity of glutathione transferase zeta (GSTZ1-1) in rat tissues. Drug Metab. Dispos. 30, 616-625.
15. Lin, E. L., Mattox, J. K., and Daniel, F. B. (1993). Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat. J. Toxicol. Environ. Health 38, 19-32.
16. Lipscomb, J. C., Mahle, D. A., Brashear, W. T., and Barton, H. A. (1995). Dichloroacetic acid: Metabolism in cytosol. Drug Metab. Dispos. 23, 1202-1205.
17. Lochhead, K. M., Kharasch, E. D., and Zager, R. A. (1997). Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury. Am. J. Pathol. 150, 2209-2221.
18. Lock, E. A., and Ishmael, J. (1998). The nephrotoxicity and hepatotoxicity of 1,1,2,2-tetrafluoroethyl-L-cysteine in the rat. Arch. Toxicol. 72, 347-354.
19. Madelian, V., and Warren, W. A. (1977). Defluorination of methoxyflurane by a glutathione-dependent enzyme. Res. Commun. Chem. Pathol. Pharmacol. 16, 385-388.
20. Mazze, R. I., Cousins, M. J., and Kosek, J. C. (1972). Dose-related methoxy-flurane nephrotoxicity in rats: A biochemical and pathological correlation. Anesthesiology 36, 571-587.
21. Poldelski, V., Johnson, A., Wright, S., Rosa, V. D., and Zager, R. A. (2001). Ethylene glycol-mediated tubular injury: Identification of critical metabolites and injury pathways. Am. J. Kidney Dis. 38, 339-348.
22. Rush, G. F., and Willis, L. R. (1982). Renal tubular effects of sodium fluoride. J. Pharmacol. Exp. Ther. 223, 275-279.
23. Stacpoole, P. W., Henderson, G. N., Yan, Z. M., and James, M. O. (1998). Clinical pharmacology and toxicology of dichloroacetate. Environ. Health Perspect. 106(Suppl. 4), 989-994.
24. Sylvester, S. R., Kato-Weinstein, J., and Schultz, I. R. (2002). Enantioselective metabolism and inhibition of glutathione transferase-zeta by bromochloroacetic acid. Toxicol. Sci. 66(Suppl. 1), 227 (Abstract).
25. Taylor, J. M., Scott, J. K., Maynard, E. A., Smith, F. A., and Hodge, H. C. (1961). Toxic effects of fluoride on the rat kidney: I. Acute injury from single large doses. Toxicol. Appl. Pharmacol. 3, 278-289.
26. Tong, Z., Board, P. G., and Anders, M. W. (1998a). Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331, 371-374.
27. Tong, Z., Board, P. G., and Anders, M. W. (1998b). Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other α-haloacids. Chem. Res. Toxicol. 11, 1332-1338.
28. Tzeng, H.-F., Blackburn, A. C., Board, P. G., and Anders, M. W. (2000). Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem. Res. Toxicol. 13, 231-236.
29. Uden, P. C., and Miller, J. W. (1983). Chlorinated acids and chloral in drinking water. J. Am. Water Works Assoc. 75, 524-527.
30. Usuda, K., Kono, K., Dote, T., Nishiura, H., and Tagawa, T. (1999). Usefulness of the assessment of urinary enzyme leakage in monitoring acute fluoride nephrotoxicity. Arch. Toxicol. 73, 346-351.
31. Van Dyke, R. A. (1966). Metabolism of volatile anesthetics: III. Induction of microsomal dechlorinating and ether-cleaving enzymes. J. Pharmacol. Exp. Ther. 154, 364-369.
32. Whitehouse, S., Cooper, R. H., and Randle, P. J. (1974). Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem. J. 141, 761-774.
33. Yin, H., Anders, M. W., and Jones, J. P. (1996). Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: Electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation. Chem. Res. Toxicol. 9, 50-57.
34. Zager, R. A., and Iwata, M. (1997). Inorganic fluoride. Divergent effects on human proximal tubular cell viability. Am. J. Pathol. 150, 735-745.